6:00 PM
 | 
Feb 01, 2013
 |  BC Extra  |  Top Story

RaQualia, Interprotein in drug discovery deal

RaQualia Pharma Inc. (JASDAQ:4579) and Interprotein Corp. (Osaka, Japan) partnered to discover and develop protein-protein interaction inhibitors for undisclosed pain indications. The companies said RaQualia will...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >